Humana is a leading health insurance company that provides a wide range of health and wellness solutions to individuals, families, and employers. The organization offers Medicare Advantage plans, Medicaid services, and individual health insurance policies, focusing on enhancing the health and well-being of its members. Additionally, Humana invests in technology and innovative care management services, aiming to improve healthcare delivery and patient outcomes. The company is dedicated to integrating medical and wellness services to create a comprehensive approach to health management for its customers. Read More
DataMeds AI, Inc. (NASDAQ:MEDS) today announced that it has implemented cost control measures, primarily through reductions in corporate management positions, to focus the workforce spend on commercializing ChemoFx® as a diagnostic lab test to help oncologists inform their chemotherapy regimen selection, initially for gynecologic cancers only.
Humana Inc. (NYSE: HUM) today announced it has entered into a new joint venture agreement with funds and accounts managed by HPS Investment Partners, a part of BlackRock (“BlackRock”), to manage and operate an existing network of nearly 150 CenterWell Senior Primary Care clinics that currently sit within joint ventures owned by funds affiliated with WCAS and CenterWell. The new joint venture, majority owned by BlackRock and minority owned by CenterWell, will replace the current CenterWell and WCAS joint ventures that were instrumental in successfully scaling CenterWell into the nation’s largest provider of senior-focused value-based primary care over the last seven years.
Humana Inc. (NYSE: HUM) will release its financial results for the third quarter 2026 (3Q26), as well as prepared management remarks (in PDF format), at 6:00 a.m. Eastern time on November 6, 2026. The company will host a live question-and-answer session at 8:00 a.m. Eastern time that morning to discuss its financial results for the quarter and earnings guidance for 2026.
InvidiaTrade ve la inteligencia artificial como una herramienta para ayudar a los traders a analizar su comportamiento, identificar errores recurrentes y construir procesos de toma de decisiones más estructurados.
DataMeds AI, Inc. (NASDAQ:MEDS) today announced that its recently acquired CLIA-certified precision oncology laboratory subsidiary Helomics Corporation has received a Medicaid coverage determination in gynecologic cancers for the ChemoFx® Assay.
What Happened? Shares of health insurance company Humana (NYSE:HUM) jumped 16.8% in the pre-market session after Robert W. Baird upgraded the company to Outp...
Humana Inc. (NYSE: HUM), a leading consumer healthcare company focused on helping people achieve their best health, today announced improved Star Ratings for 2027, highlighted by 95% of its Medicare Advantage members being enrolled in plans rated 4.0 stars or above by the Centers for Medicare and Medicaid Services (CMS). Additionally, 42% of Humana Medicare Advantage members are enrolled in 4.5-star plans for 2027.
Generating cash is essential for any business, but not all cash-rich companies are great investments. Some produce plenty of cash but fail to allocate it eff...
Humana Inc. (NYSE: HUM) and the University of Louisville today announced the publication of a new economic impact report examining Humana’s contributions across the state. The analysis, authored by University of Louisville applied economist Thomas E. Lambert, PhD, found that Humana’s operations generated nearly $20 billion in economic activity across Kentucky in 2025, supporting jobs, businesses and communities throughout the Commonwealth.
MIAMI, FL, October 5, 2026 -- New psychiatric practice next to Jackson South Medical Center offers evaluations and medication management in English and Spanish, in person and by telehealth across Florida
Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit...
As Medicare’s Annual Election Period (AEP) begins Oct. 15, Humana is offering 2027 Medicare Advantage plans designed to deliver high-value coverage with affordable monthly premiums. Members will have continued access to the benefits they value most – including $0 cost-sharing on in-network primary care visits and labs plus dental, vision, and hearing coverage. Additional 2027 highlights include:
MedicarePlans.com analysis finds 1,148 new Medicare Plan-ID/segments and 1,229 departures for 2027, alongside 35% C-SNP growth, higher cost exposure among continuing MA-PD plans, and declining Medicare Advantage plan availability across 29 states and jurisdictions.
